Home/Filings/4/0000950170-25-056492
4//SEC Filing

Duarte Ira 4

Accession 0000950170-25-056492

CIK 0000818033other

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 9:57 AM ET

Size

6.9 KB

Accession

0000950170-25-056492

Insider Transaction Report

Form 4
Period: 2025-04-19
Duarte Ira
EVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-04-19+3,875124,455 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-04-19+3,87542,617 total
    Exercise: $0.00Common Stock (3,875 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001488864

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 9:57 AM ET
Size
6.9 KB